The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Broxmeyer HE, 1983, Lactoferrin, transferrin and acidic isoferritins, regulatory molecules with potential therapeutic value in leukemia, 9, 83
Bagby GC, 1989, Regulation of granulopoiesis, the lactoferrin controversy, 15, 386
Levy O., 2004, Antimicrobial proteins and peptides, anti-infective molecules of mammalian leukocytes, 76, 909
Legrand D, 2005, Lactoferrin, a modulator of immune and inflammatory responses, 62, 2549
Gifford JL, 2005, Lactoferricin, a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties, 62, 2588
Suzuki YA, 2005, Mammalian lactoferrin receptors, structure and function, 62, 2560
Valenti P, 2005, Lactoferrin, an important host defence against microbial and viral attack, 62, 2576
Ward PP, 2005, Multifunctional roles of lactoferrin, a critical overview, 62, 2540
Bennett RM, 1976, A solid‐phase radioimmunoassay for the measurement of lactoferrin in human plasma, variations with age, sex, and disease, 88, 156
Van Berkel PH, 1997, N‐terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA, Biochem J, 328, 145, 10.1042/bj3280145
Legrand D, 1997, The N‐terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T‐cells, Biochem J, 327, 841, 10.1042/bj3270841
Hanson LA, 1995, Anti‐inflammatory capacities of human milk, lactoferrin and secretory IgA inhibit endotoxin-induced cytokine release, 371, 669
Zimecki M, 1996, Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines, Arch Immunol Ther Exp (Warsz), 44, 51
Cumberbatch M, 2003, IL‐1beta‐induced Langerhans' cell migration and TNF‐alpha production in human skin, regulation by lactoferrin, 132, 352
Teraguchi S, 2004, Protection against infections by oral lactoferrin, evaluation in animal models, 17, 231
Nagler R, 1996, Major salivary gland dysfunction in human acute and chronic graft‐versus‐host disease (GVHD), Bone Marrow Transplant, 17, 219
Gratwohl A, 2005, Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias, an EBMT analysis of lethal infectious complications and changes over calendar time, 36, 757
Xun CQ, 1994, Effect of total body irradiation, busulfan‐cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft‐versus‐host disease in H‐2‐incompatible transplanted SCID mice, Blood, 83, 2360, 10.1182/blood.V83.8.2360.2360
Hill GR, 1997, Total body irradiation and acute graft‐versus‐host disease, the role of gastrointestinal damage and inflammatory cytokines, 90, 3204
Goker H, 2001, Acute graft‐vs‐host disease, pathobiology and management, 29, 259
Miyauchi H, 1998, Bovine lactoferrin stimulates the phagocytic activity of human neutrophils, identification of its active domain, 187, 34
Zhang GH, 1999, Neutralization of endotoxin in vitro and in vivo by a human lactoferrin‐derived peptide, Infect Immunol, 67, 1353, 10.1128/IAI.67.3.1353-1358.1999
Lupetti A, 2003, 99mTc‐antimicrobial peptides, promising candidates for infection imaging, 47, 238